- Home
- GRPN vs TNGX Comparison
GRPN vs TNGX Comparison
Compare GRPN & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRPN
- TNGX
- Stock Information
- Founded
- GRPN 2008
- TNGX 2014
- Country
- GRPN United States
- TNGX United States
- Employees
- GRPN N/A
- TNGX N/A
- Industry
- GRPN Advertising
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- GRPN Consumer Discretionary
- TNGX Health Care
- Exchange
- GRPN Nasdaq
- TNGX Nasdaq
- Market Cap
- GRPN 473.0M
- TNGX 413.6M
- IPO Year
- GRPN 2011
- TNGX N/A
- Fundamental
- Price
- GRPN $11.57
- TNGX $2.97
- Analyst Decision
- GRPN Hold
- TNGX Strong Buy
- Analyst Count
- GRPN 3
- TNGX 8
- Target Price
- GRPN $17.00
- TNGX $13.14
- AVG Volume (30 Days)
- GRPN 1.6M
- TNGX 1.4M
- Earning Date
- GRPN 11-12-2024
- TNGX 11-06-2024
- Dividend Yield
- GRPN N/A
- TNGX N/A
- EPS Growth
- GRPN N/A
- TNGX N/A
- EPS
- GRPN 0.52
- TNGX N/A
- Revenue
- GRPN $499,894,000.00
- TNGX $43,383,000.00
- Revenue This Year
- GRPN N/A
- TNGX $27.73
- Revenue Next Year
- GRPN $0.32
- TNGX N/A
- P/E Ratio
- GRPN $21.79
- TNGX N/A
- Revenue Growth
- GRPN N/A
- TNGX 15.67
- 52 Week Low
- GRPN $7.75
- TNGX $2.70
- 52 Week High
- GRPN $19.56
- TNGX $13.01
- Technical
- Relative Strength Index (RSI)
- GRPN 56.21
- TNGX 32.57
- Support Level
- GRPN $11.23
- TNGX $2.77
- Resistance Level
- GRPN $13.19
- TNGX $3.29
- Average True Range (ATR)
- GRPN 0.83
- TNGX 0.28
- MACD
- GRPN 0.06
- TNGX 0.02
- Stochastic Oscillator
- GRPN 59.56
- TNGX 13.58
About GRPN Groupon Inc.
Groupon Inc acts as the middleman between consumers and merchants, offering a variety of products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.